127 related articles for article (PubMed ID: 8245034)
1. Structural and functional characterization of the HPV16 E7 protein expressed in bacteria.
Pahel G; Aulabaugh A; Short SA; Barnes JA; Painter GR; Ray P; Phelps WC
J Biol Chem; 1993 Dec; 268(34):26018-25. PubMed ID: 8245034
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
Stirdivant SM; Huber HE; Patrick DR; Defeo-Jones D; McAvoy EM; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1992 May; 12(5):1905-14. PubMed ID: 1314947
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein.
Patrick DR; Oliff A; Heimbrook DC
J Biol Chem; 1994 Mar; 269(9):6842-50. PubMed ID: 8120046
[TBL] [Abstract][Full Text] [Related]
4. One-step purification of recombinant human papillomavirus type 16 E7 oncoprotein and its binding to the retinoblastoma gene product.
Kasher MS; Wakulchik M; Cook JA; Smith MC
Biotechniques; 1993 Apr; 14(4):630-41. PubMed ID: 8386522
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.
Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T
J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
Heck DV; Yee CL; Howley PM; Münger K
Proc Natl Acad Sci U S A; 1992 May; 89(10):4442-6. PubMed ID: 1316608
[TBL] [Abstract][Full Text] [Related]
8. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of His-tagged HPV16 E7 protein active in pRb binding.
Mirecka EA; Rudolph R; Hey T
Protein Expr Purif; 2006 Aug; 48(2):281-91. PubMed ID: 16814565
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of transformation by the human papillomaviruses.
Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
[TBL] [Abstract][Full Text] [Related]
12. Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein.
Clements A; Johnston K; Mazzarelli JM; Ricciardi RP; Marmorstein R
Biochemistry; 2000 Dec; 39(51):16033-45. PubMed ID: 11123931
[TBL] [Abstract][Full Text] [Related]
13. Functional oligomerization of purified human papillomavirus types 16 and 6b E7 proteins expressed in Escherichia coli.
Chinami M; Sasaki S; Hachiya N; Yuge K; Ohsugi T; Maeda H; Shingu M
J Gen Virol; 1994 Feb; 75 ( Pt 2)():277-81. PubMed ID: 8113748
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product.
Imai Y; Matsushima Y; Sugimura T; Terada M
J Virol; 1991 Sep; 65(9):4966-72. PubMed ID: 1870208
[TBL] [Abstract][Full Text] [Related]
15. Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay.
Dong WL; Caldeira S; Sehr P; Pawlita M; Tommasino M
J Virol Methods; 2001 Oct; 98(1):91-8. PubMed ID: 11543887
[TBL] [Abstract][Full Text] [Related]
16. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.
Wong HK; Ziff EB
J Virol; 1996 Jan; 70(1):332-40. PubMed ID: 8523545
[TBL] [Abstract][Full Text] [Related]
17. Chemical synthesis of human papillomavirus type 16 E7 oncoprotein: autonomous protein domains for induction of cellular DNA synthesis and for trans activation.
Rawls JA; Pusztai R; Green M
J Virol; 1990 Dec; 64(12):6121-9. PubMed ID: 2173783
[TBL] [Abstract][Full Text] [Related]
18. Characterization of functional HPV-16 E7 protein produced in Escherichia coli.
Patrick DR; Zhang K; Defeo-Jones D; Vuocolo GR; Maigetter RZ; Sardana MK; Oliff A; Heimbrook DC
J Biol Chem; 1992 Apr; 267(10):6910-5. PubMed ID: 1551900
[TBL] [Abstract][Full Text] [Related]
19. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
20. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes.
Jewers RJ; Hildebrandt P; Ludlow JW; Kell B; McCance DJ
J Virol; 1992 Mar; 66(3):1329-35. PubMed ID: 1310752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
